Mylan Pharmaceuticals, a subsidiary of Mylan based in Morgantown, W.Va., is a market leader in researching, developing, manufacturing, marketing and distributing generic pharmaceutical products in a variety of sophisticated dosage forms. Since 1961, Mylan Pharmaceuticals has held a long-standing reputation for quality, integrity and exemplary service and maintains its commitment to increasing and protecting consumer access to affordable pharmaceuticals.
Today, Mylan Pharmaceuticals has one of the largest product portfolios in the U.S. among all generic pharmaceutical companies, consisting of more than 200 products. According to IMS Health, one of every 12 prescriptions dispensed in the U.S. is a Mylan product.1 The company pioneered and continues to specialize in groundbreaking delivery technologies and difficult-to-manufacture and formulate pharmaceuticals that treat diseases ranging from angina to arthritis, depression to diabetes, pain to Parkinson's disease, and schizophrenia to sleep disorders.
The generics industry continues to grow as an aging population, a strong desire to reduce health care outlays, and an increasing reliance on generics continue to fuel demand. With a manufacturing capacity of approximately 35 million doses, Mylan Pharmaceuticals is armed and ready to continue to seamlessly and efficiently deliver high quality products at competitive prices.
- IMS Health, Sept. 2009.